Hypercalcemia in a renal transplant recipient suffering with Pneumocystis carinii pneumonia

Am J Kidney Dis. 2002 Feb;39(2):E8. doi: 10.1053/ajkd.2002.30578.

Abstract

Hypercalcemia occurs frequently after renal transplantation. Preexisting hyperparathyroidism is the most common cause of post-transplantation hypercalcemia. We describe a renal transplant recipient infected with Pneumocystis carinii pneumonia (PCP) who developed hypercalcemia, elevated 1,25-dihydroxyvitamin D, and suppressed parathyroid hormone levels. This phenomenon mimics the extrarenal production of 1,25-dihydroxyvitamin D by activated alveolar macrophages in granulomatous diseases with hypercalcemia. To the best of our knowledge, this is the first report of 1,25-dihydroxyvitamin D-mediated hypercalcemia caused by PCP in a renal transplant recipient. This entity should be included in the differential diagnosis for renal transplant recipients with hypercalcemia, especially in patients who develop lung infections.

Publication types

  • Case Reports

MeSH terms

  • Diagnosis, Differential
  • Humans
  • Hypercalcemia / diagnosis
  • Hypercalcemia / etiology*
  • Hypercalcemia / therapy
  • Kidney Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Pneumonia, Pneumocystis / diagnostic imaging
  • Pneumonia, Pneumocystis / drug therapy
  • Pneumonia, Pneumocystis / etiology*
  • Tomography, X-Ray Computed